NASDAQ: CGON - CG Oncology, Inc.

Доходность за полгода: -11.19%

График акции CG Oncology, Inc.


О компании

CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients.

Подробнее
It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California.

Цена ао 36.52
Выручка 0.0104
Число акций ао 0.06348 млрд
Сайт https://cgoncology.com
Валюта usd
ISIN US1569441009
IPO date 2024-01-25
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Изменение цены за день: -1.2973% (37)
Изменение цены за неделю: +4.85% (34.83)
Изменение цены за месяц: +1.2195% (36.08)
Изменение цены за 3 месяца: +7.76% (33.89)
Изменение цены за полгода: -11.19% (41.12)

Недооценка

Название Значение Оценка
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Итого: 2.5

Эффективность

Название Значение Оценка
ROA, % -28.01 0
ROE, % -31.36 0
Итого: 0

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA 0 10
Итого: 10

Импульс роста

Название Значение Оценка
Доходность Revenue, % -98.04 0
Доходность Ebitda, % 340.08 10
Доходность EPS, % 278.68 10
Итого: 8

ETF Доля, % Доходность за год, % Дивиденды, %
Avantis U.S. Equity ETF 0.00148 30.97 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.88739 44.18 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.05933 28.44 1.59225
BNY Mellon US Small Cap Core Equity ETF 0.08551 26.66 1.75333
Convergence Long/Short Equity ETF -0.16995 38.88 1.56428
Fidelity MSCI Health Care Index ETF 0.00932 20.77 1.46057
Goldman Sachs Future Health Care Equity ETF 0.70991 19.78 0.84646
ProShares Hedge Replication ETF 0.00524 8.61 1.47892
Humankind US Stock ETF 0.01096 23.06 1.99919
iShares Morningstar Small-Cap ETF 0.01919 26.74 1.60498
iShares Morningstar Small-Cap Growth ETF 0.03872 27.90 0.72598
iShares Russell 2000 Growth ETF 0.08274 27.81 0.6026
iShares Russell 3000 ETF 0.00333 33.65 1.43482
iShares Morningstar Small-Cap ETF 0.01919 26.74 1.60498
iShares Morningstar Small-Cap Growth ETF 0.03872 27.90 0.72598
Direxion Daily S&P Biotech Bull 3x Shares 0.15912 70.14 0.25924
Schwab U.S. Small-Cap ETF 0.02105 26.50 1.51433
Schwab U.S. Broad Market ETF 0.00143 33.93 1.43354
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.06366 23.96 1.66828
ProShares UltraPro Russell2000 0.01961 56.21 1.47873
Vanguard Small Cap Value ETF 0.03 28.51 2.19419
Vanguard Russell 3000 ETF 0 34.00 1.43817
Vanguard Russell 2000 Growth ETF 0.04 27.95 0.60264
Vanguard Russell 2000 ETF 0.03 27.12 1.48801

Руководитель Должность Оплата Год рождения
Mr. Arthur Kuan Chairman & CEO 640.97k 1991 (33 года)
Mr. Ambaw Bellete M.S. President & COO 1.06M 1971 (53 года)
Dr. Vijay Kasturi M.D. Chief Medical Officer 212.24k 1968 (56 лет)
Ms. Corleen M. Roche CFO & Secretary N/A 1967 (57 лет)
Ms. Amy Steele Vice President of Finance, Accounting & Administration N/A
Mr. Swapnil Bhargava Ph.D. Chief Technical Officer N/A
Mr. Bing Kung Vice President of Corporate Development N/A
Mr. Joshua F. Patterson General Counsel & Chief Compliance Officer 1976 (48 лет)

Адрес: United States, Irvine. CA, 400 Spectrum Center Drive - открыть в Google картах, открыть Яндекс картах
Сайт: https://cgoncology.com